Conditions: Epilepsy, Complex Partial
Keywords: Epileptic Seizures Seizure Disorder Seizures Convulsions Anticonvulsant Anticonvulsive Antiepileptic Ganaxolone
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 11
Healthy volunteers: no

Brief summary:
This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.

Detailed description:

Arms:
arm 1: all subjects participating in 0602 are receiving ganaxolone for seizure control

Interventions: intervention 1: ganaxolone
Intervention descriptions: intervention 1: liquid suspension, 50 mg/mL, up to 500 mg/day TID or 1500 mg/day, up to 1 year

Protocol document: